Global Blood Therapeutics

171 Oyster Point Blvd., Suite 300
South San Francisco
United States

Tel: (650) 741-7700


Show articles for this employer

About Global Blood Therapeutics

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. GBT’s lead product candidate is voxelotor (formerly known as GBT440), an oral, once-daily therapy that modulates hemoglobin’s affinity for oxygen, which the company believes inhibits hemoglobin polymerization in sickle cell disease.

45 jobs with Global Blood Therapeutics